droxidopa has been researched along with levodopa in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (50.00) | 18.7374 |
| 1990's | 19 (32.76) | 18.2507 |
| 2000's | 5 (8.62) | 29.6817 |
| 2010's | 5 (8.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, SH; Chairoungdua, A; Endou, H; Kanai, Y; Kim, DK; Matsuo, H | 1 |
| Falck, B; Hardebo, JE; Owman, C | 1 |
| Burke, WH; EL Halawani, ME | 1 |
| Hashizume, K | 1 |
| de Wied, D; Spaapen-Kok, WB; Van Ree, JM; Versteeg, DH | 1 |
| Cox, B; Tha, SJ | 1 |
| Chihara, K; Imura, H; Kato, Y; Ogo, S | 1 |
| Narabayashi, H | 5 |
| Pi, WP | 1 |
| Abe, T; Nozaki, Y; Takahashi, J; Takahashi, S; Tohgi, H; Ueno, M | 1 |
| Gromova, EA; Semenova, TP | 1 |
| Kagamihara, Y; Nagaoka, M; Nakajima, Y; Tanaka, R | 1 |
| Hirose, Y; Kajita, S; Mizukawa, K; Ogawa, N; Ohara, S; Watanabe, Y | 1 |
| Nagatsu, T | 1 |
| Nagatsu, T; Naoi, M | 1 |
| Kondo, T; Nagatsu, T; Narabayashi, H; Yokochi, F | 1 |
| Karai, N; Kato, T; Katsube, J; Katsuyama, M; Nakamura, M | 1 |
| Imai, H; Komiya, T; Narabayashi, H; Usui, S | 1 |
| Lyman, CP; O'Brien, RC | 1 |
| Higurashi, M; Nomura, Y; Segawa, M | 1 |
| Reches, A | 1 |
| Fahn, S; Jackson-Lewis, V; Reches, A | 1 |
| Ogawa, N; Takayama, H; Yamamoto, M | 1 |
| Feigenbaum, JJ; Fishman, RH; Klawans, HL; Yanai, J | 1 |
| Feldman, JM; Klatt, C; Seigler, HF; Vervaert, C | 1 |
| Hayashi, A; Kondo, T; Nagatsu, T; Narabayashi, H; Suzuki, T | 1 |
| Gamaniel, K; Osuide, G; Wambebe, C | 1 |
| Kuroda, H; Nukina, I; Ogawa, N; Ota, Z; Yamamoto, M | 1 |
| Quinn, NP | 1 |
| Bird, JL; Feldman, JM; Zern, RT | 1 |
| Männistö, PT; Mattila, J; Tuomisto, J | 1 |
| Maruyama, W; Naoi, M; Narabayashi, H | 2 |
| Pestana, M; Soares-Da-Silva, P | 1 |
| Lange, KW; Riederer, P; Youdim, MB | 1 |
| Lin, CH; Pi, WP | 1 |
| Yanagisawa, N | 1 |
| Achiron, A; Goldberg, H; Goren, M; Melamed, E; Sroka, H; Ziv, I; Zoldan, Y | 1 |
| Abe, T; Takahashi, S; Tohgi, H | 1 |
| Maruyama, W; Nakahara, D; Naoi, M | 1 |
| Goshima, Y; Misu, Y; Miyamae, T; Yue, JL | 1 |
| Nakajima, T | 1 |
| Fujita, K; Furukawa, N; Goshima, Y; Misu, Y; Miyamae, T; Nishihama, M; Okumura, F | 1 |
| Ebinger, G; Michotte, Y; Sarre, S; Smolders, I; Thorré, K | 1 |
| Kikuchi, K; Nishino, K; Ohyu, H | 1 |
| Ikemoto, K | 1 |
| Kamimura, N; Murayama, N; Sunagane, N; Terawaki, Y; Uruno, T; Yoshinobu, E | 1 |
| Kaufmann, H | 2 |
| Bordet, R; Defebvre, L; Devos, D | 1 |
| Enomoto, T; Noda, T; Nohmi, T; Ono, T; Saito, Y; Seki, M; Takeda, N; Uehara, Y | 1 |
| Nishijima, K; Saito, S; Shioda, K | 1 |
| Canning, SD; Wang, XP; Zhang, LL | 1 |
| Goldstein, DS; Holmes, C; Lamotte, G; Sullivan, P | 1 |
14 review(s) available for droxidopa and levodopa
| Article | Year |
|---|---|
[Recent progress in treatment of Parkinson's disease].
Topics: Droxidopa; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Substantia Nigra; Thalamus | 1990 |
[Pathogenic substances in Parkinson disease and new therapeutics considering the etiologic mechanism].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biopterins; Dopamine Agents; Droxidopa; Humans; Levodopa; Nerve Tissue; Parkinson Disease; Pyridines; Serine | 1988 |
Noradrenergic influences on dopaminergic function and the pharmacology of dihydroxyphenylserine (DOPS): implication for Parkinson's disease.
Topics: Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Carbidopa; Dopamine; Droxidopa; Levodopa; Locus Coeruleus; Myocardium; Norepinephrine; Pargyline; Parkinson Disease; Serine; Stereoisomerism; Tyrosine | 1985 |
[Mechanism of the development of akinesia in Parkinson's disease --with reference to L-threo-DOPS therapy].
Topics: Adult; Aged; Antiparkinson Agents; Corpus Striatum; Dopamine; Dopamine beta-Hydroxylase; Droxidopa; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Terminology as Topic | 1983 |
Anti-parkinsonian drugs today.
Topics: Amantadine; Amphetamines; Antiparkinson Agents; Brain Chemistry; Catechol O-Methyltransferase Inhibitors; Dopamine beta-Hydroxylase; Droxidopa; Humans; Kinetics; Levodopa; Mental Disorders; Parasympatholytics; Parkinson Disease; Selegiline | 1984 |
Three types of akinesia in the progressive course of Parkinson's disease.
Topics: Brain Mapping; Corpus Striatum; Dopamine; Dopamine Agents; Droxidopa; Globus Pallidus; Humans; Levodopa; Movement Disorders; Neural Pathways; Parkinson Disease; Receptors, Dopamine; Thalamic Nuclei | 1993 |
Recent advances in pharmacological therapy of Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agents; Droxidopa; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Levodopa; NAD; Neurologic Examination; Parkinson Disease; Receptors, Dopamine | 1993 |
[Recent progress of therapy in patients with Parkinson's disease].
Topics: Brain; Bromocriptine; Delayed-Action Preparations; Droxidopa; Drug Resistance; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine | 1993 |
Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Depressive Disorder; Droxidopa; Histidine; Humans; Levodopa; Parkinson Disease | 1996 |
Evidence suggesting the role of norepinephrine deficiency in late stages of Parkinson's disease.
Topics: Antiparkinson Agents; Disease Progression; Dopamine beta-Hydroxylase; Droxidopa; Globus Pallidus; Humans; Levodopa; Norepinephrine; Parkinson Disease; Thalamus | 1999 |
[Human striatal D-neurons and their significance].
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Corpus Striatum; Dopamine; Droxidopa; Humans; Levodopa; Mental Disorders; Neurons; Norepinephrine; Parkinson Disease; Pluripotent Stem Cells | 2002 |
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Norepinephrine; United States | 2008 |
[Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
Topics: Accidental Falls; Antiparkinson Agents; Cholinergic Agents; Dopamine Agents; Droxidopa; Gait Disorders, Neurologic; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Serotonin Receptor Agonists; Synaptic Transmission | 2010 |
Freezing of Gait in Parkinsonism and its Potential Drug Treatment.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Botulinum Toxins; Droxidopa; Gait Disorders, Neurologic; Humans; Indans; Levodopa; Methylphenidate; Middle Aged; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Selegiline; Treatment Outcome | 2016 |
2 trial(s) available for droxidopa and levodopa
| Article | Year |
|---|---|
L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
Topics: Aged; Clinical Trials as Topic; Droxidopa; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Serine | 1985 |
The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antiparkinson Agents; Biogenic Monoamines; Cerebral Ventricles; Combined Modality Therapy; Dopamine; Droxidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Reference Values; Stereotaxic Techniques; Thalamus | 1996 |
42 other study(ies) available for droxidopa and levodopa
| Article | Year |
|---|---|
Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.
Topics: Amino Acid Sequence; Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Animals; Anion Transport Proteins; Bacterial Proteins; Carrier Proteins; Cloning, Molecular; Escherichia coli Proteins; Female; Intestine, Small; Kinetics; Levodopa; Mice; Molecular Sequence Data; Oocytes; Phenylalanine; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity; Tryptophan; Tyrosine; Xenopus laevis | 2001 |
A comparative study on the uptake and subsequent decarboxylation of monoamine precursors in cerebral microvessels.
Topics: 5-Hydroxytryptophan; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Blood-Brain Barrier; Brain; Cats; Cattle; Cricetinae; Decarboxylation; Dogs; Droxidopa; Female; Guinea Pigs; Haplorhini; Humans; Levodopa; Male; Mice; Microcirculation; Microscopy, Fluorescence; Rabbits; Rats; Serine; Species Specificity; Swine | 1979 |
Role of catecholamines in photoperiodically-induced gonadal development in Coturnix quail.
Topics: Animals; Brain; Catecholamines; Coturnix; Ditiocarb; Dopamine; Droxidopa; Epinephrine; Levodopa; Light; Male; Methyltyrosines; Norepinephrine; Radiation Effects; Testis | 1975 |
Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Brain; Brocresine; Chlorpromazine; Cold Temperature; Ditiocarb; Droxidopa; Fenclonine; Levodopa; Male; Methyltyrosines; Oxotremorine; Rats; Thyroid Gland | 1976 |
Effects of morphine on hypothalamic noradrenaline and on pituitary-adrenal activity in rats.
Topics: Adrenocorticotropic Hormone; Animals; Droxidopa; Female; Hypothalamus; Levodopa; Male; Morphine; Norepinephrine; Pituitary-Adrenal System; Rats | 1976 |
The role of dopamine and noradrenaline in temperature control of normal and reserpine-pretreated mice.
Topics: Amantadine; Animals; Apomorphine; Body Temperature; Body Temperature Regulation; Dextroamphetamine; Dopamine; Droxidopa; Esophagus; Female; Levodopa; Male; Mice; Mice, Inbred Strains; Norepinephrine; Reserpine; Time Factors | 1975 |
Effects of drugs influencing brain catecholamines on GH release in rats with hypothalamic surgery.
Topics: Animals; Brain Mapping; Catecholamines; Chlorpromazine; Droxidopa; Growth Hormone; Hypothalamus; Levodopa; Male; Methyltyrosines; Rats | 1975 |
Effects of biogenic amine precursors on ovarian steroid-induced LH release in acutely ovariectomized rats.
Topics: 5-Hydroxytryptophan; Animals; Droxidopa; Estradiol; Female; Gonadotropin-Releasing Hormone; Levodopa; Luteinizing Hormone; Ovariectomy; Pituitary Gland; Progesterone; Rats; Rats, Inbred Strains | 1990 |
Effect of a synthetic norepinephrine precursor, L-threo-3,4- dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patients.
Topics: Carbidopa; Droxidopa; Humans; Levodopa; Middle Aged; Norepinephrine; Parkinson Disease | 1990 |
[Significance of the reciprocal relationship of monoaminergic systems of the brain in the pharmacological compensation of 6-hydroxydopamine-induced behavior disorders in animals].
Topics: Animals; Behavior, Animal; Biogenic Amines; Brain; Droxidopa; Fenclonine; Frustration; Hydroxydopamines; Levodopa; Male; Rats; Serotonin | 1989 |
The effect of L-threo-DOPS on synaptic transmission to soleus motoneuron in normal subjects and patients with Parkinson's disease.
Topics: Adult; Aged; Droxidopa; Female; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Muscles; Parkinson Disease; Reference Values; Serine; Synapses; Synaptic Transmission | 1987 |
MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Droxidopa; Levodopa; Mice; Mice, Inbred C57BL; Parkinson Disease, Secondary; Pyridines; Receptors, Muscarinic; Somatostatin | 1987 |
[L-threo-DOPS therapy and parkinsonism].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Antiparkinson Agents; Brain; Dopamine; Droxidopa; Humans; Levodopa; Norepinephrine; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Serine; Stereotaxic Techniques | 1986 |
Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl L-alanine and its analogues.
Topics: Dihydroxyphenylalanine; Droxidopa; Humans; In Vitro Techniques; Kynuramine; Levodopa; Methyldopa; Mitochondria; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Placenta; Stereoisomerism; Structure-Activity Relationship | 1987 |
Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia.
Topics: Adult; Aged; Antiparkinson Agents; Droxidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Parkinson Disease, Secondary; Serine; Shy-Drager Syndrome | 1987 |
Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain; Catecholamines; Dopamine; Droxidopa; Kinetics; Levodopa; Male; Methoxyhydroxyphenylglycol; Mice; Nialamide; Norepinephrine; Protein Precursors; Rats; Rats, Inbred Strains; Serine; Substrate Specificity | 1987 |
[Metrizamide encephalopathy in a child with hydrocephalus--effects of L-threo-DOPS on persistent disturbance of consciousness and L-dopa on extrapyramidal symptoms].
Topics: Basal Ganglia Diseases; Brain; Brain Diseases; Child; Cognition Disorders; Consciousness Disorders; Droxidopa; Electroencephalography; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Hydrocephalus; Levodopa; Metrizamide; Serine; Tomography, X-Ray Computed | 1988 |
A pharmacological study of hibernation in rodents.
Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae | 1988 |
Rett syndrome--an early catecholamine and indolamine deficient disorder?
Topics: 5-Hydroxytryptophan; Adolescent; Basal Ganglia; Catecholamines; Child; Child, Preschool; Droxidopa; Electroencephalography; Female; Humans; Intellectual Disability; Levodopa; Locus Coeruleus; Neurocognitive Disorders; Raphe Nuclei; Serotonin; Sleep, REM; Stereotyped Behavior; Syndrome | 1985 |
DL-threo-DOPS as a precursor of noradrenaline.
Topics: alpha-Methyltyrosine; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Carbidopa; Dopamine; Droxidopa; Levodopa; Male; Methyltyrosines; Myocardium; Norepinephrine; Pargyline; Rats; Rats, Inbred Strains; Reserpine; Serine; Stereotyped Behavior | 1985 |
The relative importance of dopamine and norepinephrine in mediating locomotor activity.
Topics: Adrenergic Antagonists; Amphetamines; Animals; Apomorphine; Biomechanical Phenomena; Brain Chemistry; Catecholamines; Clonidine; Corpus Striatum; Dopamine; Droxidopa; Isoproterenol; Levodopa; Limbic System; Locomotion; Neural Pathways; Neurotransmitter Agents; Norepinephrine; Nucleus Accumbens; Propranolol; Receptors, Dopamine; Reserpine; Serotonin; Serotonin Antagonists; Substantia Nigra; Tetrahydronaphthalenes | 1983 |
Therapy of malignant hamster insulinomas with monoamine precursors.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Animals; Cricetinae; Dopamine; Droxidopa; Levodopa; Neoplasms, Experimental; Norepinephrine; Pancreatic Neoplasms; Pargyline; Serine; Serotonin | 1981 |
DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism.
Topics: Aged; Antiparkinson Agents; Blood-Brain Barrier; Carboxy-Lyases; Dopamine; Droxidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Serine | 1984 |
Influence of levodopa, apomorphine and 3,4-dihydroxyphenylserine (DOPS) on strychnine-induced seizures in mice.
Topics: Animals; Apomorphine; Droxidopa; Levodopa; Mice; Phentolamine; Propranolol; Seizures; Serine; Strychnine | 1984 |
Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
Topics: Aged; Benserazide; Droxidopa; Gait; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serine | 1984 |
Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster.
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Cricetinae; Dopamine; Droxidopa; Insulin; Insulin Secretion; Islets of Langerhans; Levodopa; Mesocricetus; Norepinephrine; Serotonin; Tranylcypromine | 1980 |
Further evidence of the dual role of noradrenaline in regulation of thyrotrophin secretion in male rats.
Topics: alpha-Methyltyrosine; Animals; Brain; Dopamine; Droxidopa; Fusaric Acid; Levodopa; Male; Methyltyrosines; Norepinephrine; Pineal Gland; Rats; Serotonin; Thyrotropin | 1981 |
[The effect of droxidopa on the monoamine metabolsim in the human brain].
Topics: Adult; Biogenic Monoamines; Brain; Droxidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1994 |
Outflow of dopamine and noradrenaline originating from L-dopa and L-threo-DOPS in rat renal tissues.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Droxidopa; In Vitro Techniques; Kidney; Levodopa; Male; Monoamine Oxidase; Norepinephrine; Rats; Rats, Wistar | 1994 |
Effects of monoamine precursors on food intake in male rats.
Topics: 5-Hydroxytryptophan; Animals; Droxidopa; Eating; Levodopa; Male; Rats; Rats, Sprague-Dawley | 1993 |
Primary progressive freezing gait.
Topics: Aged; Diagnosis, Differential; Droxidopa; Female; Gait; Humans; Levodopa; Locomotion; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease; Posture; Tomography, X-Ray Computed | 1993 |
The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients.
Topics: Aged; Carbidopa; Dopamine; Dose-Response Relationship, Drug; Droxidopa; Female; Gait; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease | 1993 |
A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
Topics: Animals; Brain; Corpus Striatum; Droxidopa; Levodopa; Male; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Time Factors | 1994 |
Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
Topics: Animals; Blood Pressure; Bradycardia; Depression, Chemical; Dose-Response Relationship, Drug; Droxidopa; Drug Interactions; Heart Rate; Hypotension; Levodopa; Male; Rats; Rats, Wistar; Solitary Nucleus; Stereoisomerism | 1996 |
An L-DOPA-like depressor action of L-threo-dihydroxyphenyl-serine in the rat caudal ventrolateral medulla.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Droxidopa; Glutamic Acid; Heart Rate; Levodopa; Male; Medulla Oblongata; Microinjections; Organ Specificity; Rats; Rats, Wistar | 1997 |
Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: a microdialysis study.
Topics: 5-Hydroxytryptophan; Animals; Biotransformation; Dopamine; Dopamine Agents; Droxidopa; Extracellular Space; Hippocampus; Levodopa; Male; Microdialysis; Microinjections; Neostriatum; Norepinephrine; Rats; Rats, Wistar; Serotonin; Sodium Channel Blockers; Tetrodotoxin | 1997 |
L-DOPS-Accelerated recovery of locomotor function in rats subjected to sensorimotor cortex ablation injury: pharmacobehavioral studies.
Topics: Animals; Benserazide; Brain; Cerebral Cortex; Dopamine Agents; Droxidopa; Drug Therapy, Combination; Levodopa; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Stroke | 1999 |
[Simple method for precognition of drug interaction between oral iron and phenolic hydroxyl group-containing drugs].
Topics: Acetaminophen; Animals; Biological Availability; Biopharmaceutics; Citric Acid; Colorimetry; Droxidopa; Drug Interactions; Ferrous Compounds; Iron Compounds; Levodopa; Male; Mice; Mice, Inbred Strains; Suspensions | 2005 |
Neurogenic orthostatic hypotension: new prospects in treatment. Introduction.
Topics: Dopamine Agents; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa | 2008 |
Embryonic lethality in mice lacking mismatch-specific thymine DNA glycosylase is partially prevented by DOPS, a precursor of noradrenaline.
Topics: Animals; Chromatography, High Pressure Liquid; DNA Primers; Dopamine; Droxidopa; Embryo, Mammalian; Epigenesis, Genetic; Female; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Norepinephrine; Polymerase Chain Reaction; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; Thymine DNA Glycosylase | 2012 |
Dopamine dysregulation syndrome including mania related to coadministration of droxidopa.
Topics: Aggression; Antiparkinson Agents; Behavior, Addictive; Benzothiazoles; Bipolar Disorder; Carbidopa; Droxidopa; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease; Pramipexole; Treatment Outcome | 2012 |
Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Droxidopa; Drug Combinations; Female; Humans; Hypotension, Orthostatic; Kidney; Levodopa; Male; Middle Aged; Norepinephrine | 2019 |